Marsha Certain, MD, FACC, was an interventional cardiologist in Brunswick, Georgia, for nearly 40 years.

Alexander Fanaroff, MD, said the late-breaking BE ACTIVE clinical trial presented at ACC.24 offers a blueprint for how to get patients to be more physically active.

The popular high-fat, low-carb diet is associated with multiple short-term benefits, but they appear to diminish over time. 

AskBio, acquired by Bayer for more than $2 billion in 2020, is enrolling patients for a new clinical trial focused on the therapy's effectiveness in adult patients with non-ischemic cardiomyopathy and heart failure. 

The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky.

How have recent FDA approvals for Edwards Lifesciences and Abbott changed patient care? Andrew Rassi, MD, answered that question—and many more—in a new interview. 

Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat.

The PREVENT study, presented at ACC.24, examined more than 1,600 patients with high-risk plaques treated with either preventive PCI or medical therapy alone. Outcomes were much better for the PCI group after two years, but the findings may lead to more questions than answers. 

TAVR is noninferior to SAVR when treating low-risk patients, according to new data presented at ACC.24. In fact, it is associated with multiple benefits over surgery.

The class action lawsuit was filed in Japan to raise public awareness about the state of Google reviews, many of which the plaintiffs claim are fake.

ILD-RADS was developed to address issues with inconsistency when reading high-resolution CT scans of the lungs in patients with a suspected interstitial lung disease.